Novacyt S.A. (EPA:ALNOV)
France · Delayed Price · Currency is EUR 0.4845
+0.0315 (6.95%)
Sep 29, 2025, 5:35 PM CET
Novacyt Market Cap
Novacyt has a market cap or net worth of €31.95 million as of September 29, 2025. Its market cap has decreased by -48.53% in one year.
Market Cap
31.95M
Enterprise Value
9.26M
Revenue
23.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.48
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 31.95M, an increase of 35.62%. That is a compound annual growth rate of 2.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 31.95M | -24.78% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | 692.08M | 6,955.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.29B |
| Sanofi | 95.30B |
| Sartorius Stedim Biotech | 16.69B |
| bioMérieux | 13.34B |
| Eurofins Scientific SE | 10.82B |
| Ipsen | 9.19B |
| ABIVAX Société Anonyme | 5.31B |
| Virbac | 2.63B |